{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T04:58:51Z","timestamp":1794891531145,"version":"4.9.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:00:00Z","timestamp":1589155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:00:00Z","timestamp":1589155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Human pluripotent stem cells (hPSCs)-derived cardiovascular progenitor cells (CVPCs) are a promising source for myocardial repair, while the mechanisms remain largely unknown. Extracellular vesicles (EVs) are known to mediate cell\u2013cell communication, however, the efficacy and mechanisms of hPSC-CVPC-secreted EVs (hCVPC-EVs) in the infarct healing when given at the acute phase of myocardial infarction (MI) are unknown. Here, we report the cardioprotective effects of the EVs secreted from hESC-CVPCs under normoxic (EV-N) and hypoxic (EV-H) conditions in the infarcted heart and the long noncoding RNA (lncRNA)-related mechanisms. The hCVPC-EVs were confirmed by electron microscopy, nanoparticle tracking, and immunoblotting analysis. Injection of hCVPC-EVs into acutely infracted murine myocardium significantly improved cardiac function and reduced fibrosis at day 28 post MI, accompanied with the improved vascularization and cardiomyocyte survival at border zones. Consistently, hCVPC-EVs enhanced the tube formation and migration of human umbilical vein endothelial cells (HUVECs), improved the cell viability, and attenuated the lactate dehydrogenase release of neonatal rat cardiomyocytes (NRCMs) with oxygen glucose deprivation (OGD) injury. Moreover, the improvement of the EV-H in cardiomyocyte survival and tube formation of HUVECs was significantly better than these in the EV-N. RNA-seq analysis revealed a high abundance of the lncRNA MALAT1 in the EV-H. Its abundance was upregulated in the infarcted myocardium and cardiomyocytes treated with hCVPC-EVs. Overexpression of human MALAT1 improved the cell viability of NRCM with OGD injury, while knockdown of MALAT1 inhibited the hCVPC-EV-promoted tube formation of HUVECs. Furthermore, luciferase activity assay, RNA pull-down, and manipulation of miR-497 levels showed that MALAT1 improved NRCMs survival and HUVEC tube formation through targeting miR-497. These results reveal that hCVPC-EVs promote the infarct healing through improvement of cardiomyocyte survival and angiogenesis. The cardioprotective effects of hCVPC-EVs can be enhanced by hypoxia-conditioning of hCVPCs and are partially contributed by MALAT1 via targeting the miRNA.<\/jats:p>","DOI":"10.1038\/s41419-020-2508-y","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T16:03:58Z","timestamp":1589213038000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":172,"title":["Extracellular vesicles from human embryonic stem cell-derived cardiovascular progenitor cells promote cardiac infarct healing through reducing cardiomyocyte death and promoting angiogenesis"],"prefix":"10.1038","volume":"11","author":[{"given":"Qiang","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson Lek Wen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiujian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiliang","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zenia","family":"Tiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger Sik-Yin","family":"Foo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huang-Tian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,11]]},"reference":[{"key":"2508_CR1","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1161\/CIRCRESAHA.113.300268","volume":"113","author":"VL Roger","year":"2013","unstructured":"Roger, V. L. Epidemiology of heart failure. Circ. Res. 113, 646\u2013659 (2013).","journal-title":"Circ. Res."},{"key":"2508_CR2","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1016\/j.ijcard.2013.01.163","volume":"167","author":"G Takemura","year":"2013","unstructured":"Takemura, G., Kanoh, M., Minatoguchi, S. & Fujiwara, H. Cardiomyocyte apoptosis in the failing heart\u2014a critical review from definition and classification of cell death. Int. J. Cardiol. 167, 2373\u20132386 (2013).","journal-title":"Int. J. Cardiol."},{"key":"2508_CR3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jacc.2018.09.086","volume":"73","author":"SM Davidson","year":"2019","unstructured":"Davidson, S. M. et al. Multitarget strategies to reduce myocardial ischemia\/reperfusion injury: JACC review topic of the week. J. Am. Coll. Cardiol. 73, 89\u201399 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"2508_CR4","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nature11682","volume":"493","author":"SE Senyo","year":"2013","unstructured":"Senyo, S. E. et al. Mammalian heart renewal by pre-existing cardiomyocytes. Nature 493, 433\u2013436 (2013).","journal-title":"Nature"},{"key":"2508_CR5","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1056\/NEJM200106073442303","volume":"344","author":"AP Beltrami","year":"2001","unstructured":"Beltrami, A. P. et al. Evidence that human cardiac myocytes divide after myocardial infarction. N. Engl. J. Med. 344, 1750\u20131757 (2001).","journal-title":"N. Engl. J. Med."},{"key":"2508_CR6","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1006\/jmcc.1999.1013","volume":"31","author":"G Asemu","year":"1999","unstructured":"Asemu, G., Papousek, F., Ostadal, B. & Kolar, F. Adaptation to high altitude hypoxia protects the rat heart against ischemia-induced arrhythmias. Involvement of mitochondrial K(ATP) channel. J. Mol. Cell. Cardiol. 31, 1821\u20131831 (1999).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"2508_CR7","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1089\/ars.2010.3360","volume":"14","author":"DJ Hausenloy","year":"2011","unstructured":"Hausenloy, D. J., Lecour, S. & Yellon, D. M. Reperfusion injury salvage kinase and survivor activating factor enhancement prosurvival signaling pathways in ischemic postconditioning: two sides of the same coin. Antioxid. Redox Signal. 14, 893\u2013907 (2011).","journal-title":"Antioxid. Redox Signal."},{"key":"2508_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.267","volume":"5","author":"ZH Wang","year":"2014","unstructured":"Wang, Z. H., Liu, J. L., Wu, L., Yu, Z. & Yang, H. T. Concentration-dependent wrestling between detrimental and protective effects of H2O2 during myocardial ischemia\/reperfusion. Cell Death Dis. 5, e1297 (2014).","journal-title":"Cell Death Dis."},{"key":"2508_CR9","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1161\/CIRCRESAHA.114.300639","volume":"114","author":"S Sahoo","year":"2014","unstructured":"Sahoo, S. & Losordo, D. W. Exosomes and cardiac repair after myocardial infarction. Circ. Res. 114, 333\u2013344 (2014).","journal-title":"Circ. Res."},{"key":"2508_CR10","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature20173","volume":"541","author":"Y Nakada","year":"2017","unstructured":"Nakada, Y. et al. Hypoxia induces heart regeneration in adult mice. Nature 541, 222\u2013227 (2017).","journal-title":"Nature"},{"key":"2508_CR11","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/nrd.2017.106","volume":"16","author":"TJ Cahill","year":"2017","unstructured":"Cahill, T. J., Choudhury, R. P. & Riley, P. R. Heart regeneration and repair after myocardial infarction: translational opportunities for novel therapeutics. Nat. Rev. Drug Discov. 16, 699\u2013717 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2508_CR12","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1093\/eurheartj\/ehr166","volume":"32","author":"C Mauritz","year":"2011","unstructured":"Mauritz, C. et al. Induced pluripotent stem cell (iPSC)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction. Eur. Heart J. 32, 2634\u20132641 (2011).","journal-title":"Eur. Heart J."},{"key":"2508_CR13","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1161\/CIRCRESAHA.115.307516","volume":"118","author":"X Hu","year":"2016","unstructured":"Hu, X. et al. A large-scale investigation of hypoxia-preconditioned allogeneic mesenchymal stem cells for myocardial repair in nonhuman primates: paracrine activity without remuscularization. Circ. Res. 118, 970\u2013983 (2016).","journal-title":"Circ. Res."},{"key":"2508_CR14","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.stemcr.2015.09.011","volume":"5","author":"S Fernandes","year":"2015","unstructured":"Fernandes, S. et al. Comparison of human embryonic stem cell-derived cardiomyocytes, cardiovascular progenitors, and bone marrow mononuclear cells for cardiac repair. Stem Cell Rep. 5, 753\u2013762 (2015).","journal-title":"Stem Cell Rep."},{"key":"2508_CR15","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/nature19815","volume":"538","author":"Y Shiba","year":"2016","unstructured":"Shiba, Y. et al. Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts. Nature 538, 388\u2013391 (2016).","journal-title":"Nature"},{"key":"2508_CR16","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nbt.4162","volume":"36","author":"YW Liu","year":"2018","unstructured":"Liu, Y. W. et al. Human embryonic stem cell-derived cardiomyocytes restore function in infarcted hearts of non-human primates. Nat. Biotechnol. 36, 597\u2013605 (2018).","journal-title":"Nat. Biotechnol."},{"key":"2508_CR17","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.stem.2014.11.009","volume":"15","author":"L Ye","year":"2014","unstructured":"Ye, L. et al. Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells. Cell Stem Cell 15, 750\u2013761 (2014).","journal-title":"Cell Stem Cell"},{"key":"2508_CR18","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1161\/CIRCRESAHA.118.314216","volume":"124","author":"JL Berry","year":"2019","unstructured":"Berry, J. L. et al. Convergences of life sciences and engineering in understanding and treating heart failure. Circ. Res. 124, 161\u2013169 (2019).","journal-title":"Circ. Res."},{"key":"2508_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.stem.2011.12.013","volume":"10","author":"PW Burridge","year":"2012","unstructured":"Burridge, P. W., Keller, G., Gold, J. D. & Wu, J. C. Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. Cell Stem Cell 10, 16\u201328 (2012).","journal-title":"Cell Stem Cell"},{"key":"2508_CR20","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1161\/CIRCRESAHA.110.227512","volume":"111","author":"CL Mummery","year":"2012","unstructured":"Mummery, C. L. et al. Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circ. Res. 111, 344\u2013358 (2012).","journal-title":"Circ. Res."},{"key":"2508_CR21","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/cr.2013.102","volume":"23","author":"N Cao","year":"2013","unstructured":"Cao, N. et al. Highly efficient induction and long-term maintenance of multipotent cardiovascular progenitors from human pluripotent stem cells under defined conditions. Cell Res. 23, 1119\u20131132 (2013).","journal-title":"Cell Res."},{"key":"2508_CR22","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s11302-016-9512-9","volume":"12","author":"J Huang","year":"2016","unstructured":"Huang, J. et al. Coupling switch of P2Y-IP3 receptors mediates differential Ca(2+) signaling in human embryonic stem cells and derived cardiovascular progenitor cells. Purinergic Signal. 12, 465\u2013478 (2016).","journal-title":"Purinergic Signal."},{"key":"2508_CR23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ydbio.2015.01.012","volume":"400","author":"MJ Birket","year":"2015","unstructured":"Birket, M. J. & Mummery, C. L. Pluripotent stem cell derived cardiovascular progenitors\u2014a developmental perspective. Dev. Biol. 400, 169\u2013179 (2015).","journal-title":"Dev. Biol."},{"key":"2508_CR24","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/nature11317","volume":"489","author":"Y Shiba","year":"2012","unstructured":"Shiba, Y. et al. Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature 489, 322\u2013325 (2012).","journal-title":"Nature"},{"key":"2508_CR25","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1089\/ars.2018.7688","volume":"31","author":"J Wang","year":"2019","unstructured":"Wang, J. et al. Human embryonic stem cell-derived cardiovascular progenitors repair infarcted hearts through modulation of macrophages via activation of STAT6. Antioxid. Redox Signal. 31, 369\u2013386 (2019).","journal-title":"Antioxid. Redox Signal."},{"key":"2508_CR26","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1161\/CIRCRESAHA.117.311578","volume":"122","author":"K Zhu","year":"2018","unstructured":"Zhu, K. et al. Lack of remuscularization following transplantation of human embryonic stem cell-derived cardiovascular progenitor cells in infarcted nonhuman primates. Circ. Res. 122, 958\u2013969 (2018).","journal-title":"Circ. Res."},{"key":"2508_CR27","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1093\/eurheartj\/ehv189","volume":"36","author":"P Menasche","year":"2015","unstructured":"Menasche, P. et al. Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report. Eur. Heart J. 36, 2011\u20132017 (2015).","journal-title":"Eur. Heart J."},{"key":"2508_CR28","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jacc.2017.11.047","volume":"71","author":"P Menasch\u00e9","year":"2018","unstructured":"Menasch\u00e9, P. et al. Transplantation of human embryonic stem cell-derived cardiovascular progenitors for severe ischemic left ventricular dysfunction. J. Am. Coll. Cardiol. 71, 429\u2013438 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"2508_CR29","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1161\/CIRCRESAHA.115.307654","volume":"118","author":"R Kishore","year":"2016","unstructured":"Kishore, R. & Khan, M. More than tiny sacks: stem cell exosomes as cell-free modality for cardiac repair. Circ. Res. 118, 330\u2013343 (2016).","journal-title":"Circ. Res."},{"key":"2508_CR30","first-page":"1372","volume":"38","author":"L Barile","year":"2016","unstructured":"Barile, L., Moccetti, T., Marban, E. & Vassalli, G. Roles of exosomes in cardioprotection. Eur. Heart J. 38, 1372\u20131379 (2016).","journal-title":"Eur. Heart J."},{"key":"2508_CR31","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrcardio.2017.7","volume":"14","author":"CM Boulanger","year":"2017","unstructured":"Boulanger, C. M., Loyer, X., Rautou, P. E. & Amabile, N. Extracellular vesicles in coronary artery disease. Nat. Rev. Cardiol. 14, 259\u2013272 (2017).","journal-title":"Nat. Rev. Cardiol."},{"key":"2508_CR32","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.healun.2016.01.013","volume":"35","author":"A Kervadec","year":"2016","unstructured":"Kervadec, A. et al. Cardiovascular progenitor-derived extracellular vesicles recapitulate the beneficial effects of their parent cells in the treatment of chronic heart failure. J. Heart Lung Transplant. 35, 795\u2013807 (2016).","journal-title":"J. Heart Lung Transplant."},{"key":"2508_CR33","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1093\/eurheartj\/ehy012","volume":"39","author":"N El Harane","year":"2018","unstructured":"El Harane, N. et al. Acellular therapeutic approach for heart failure: in vitro production of extracellular vesicles from human cardiovascular progenitors. Eur. Heart J. 39, 1835\u20131847 (2018).","journal-title":"Eur. Heart J."},{"key":"2508_CR34","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev-cellbio-101512-122326","volume":"30","author":"M Colombo","year":"2014","unstructured":"Colombo, M., Raposo, G. & Thery, C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu. Rev. Cell Dev. Biol. 30, 255\u2013289 (2014).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"2508_CR35","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/ncb1596","volume":"9","author":"H Valadi","year":"2007","unstructured":"Valadi, H. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654\u2013659 (2007).","journal-title":"Nat. Cell Biol."},{"key":"2508_CR36","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1161\/CIRCRESAHA.118.312420","volume":"122","author":"J Mayourian","year":"2018","unstructured":"Mayourian, J. et al. Exosomal microRNA-21-5p mediates mesenchymal stem cell paracrine effects on human cardiac tissue contractility. Circ. Res. 122, 933\u2013944 (2018).","journal-title":"Circ. Res."},{"key":"2508_CR37","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1161\/CIRCRESAHA.118.312758","volume":"123","author":"C Xiao","year":"2018","unstructured":"Xiao, C. et al. Transplanted mesenchymal stem cells reduce autophagic flux in infarcted hearts via the exosomal transfer of mir-125b. Circ. Res. 123, 564\u2013578 (2018).","journal-title":"Circ. Res."},{"key":"2508_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.181","volume":"7","author":"J Xiao","year":"2016","unstructured":"Xiao, J. et al. Cardiac progenitor cell-derived exosomes prevent cardiomyocytes apoptosis through exosomal miR-21 by targeting PDCD4. Cell Death Dis. 7, e2277 (2016).","journal-title":"Cell Death Dis."},{"key":"2508_CR39","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.stemcr.2014.04.006","volume":"2","author":"AG-E Ibrahim","year":"2014","unstructured":"Ibrahim, A. G.-E., Cheng, K. & Marb\u00e1n, E. Exosomes as critical agents of cardiac regeneration triggered by cell therapy. Stem Cell Rep. 2, 606\u2013619 (2014).","journal-title":"Stem Cell Rep."},{"key":"2508_CR40","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1161\/CIRCRESAHA.117.305990","volume":"117","author":"M Khan","year":"2015","unstructured":"Khan, M. et al. Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction. Circ. Res. 117, 52\u201364 (2015).","journal-title":"Circ. Res."},{"key":"2508_CR41","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1002\/stem.2669","volume":"35","author":"WH Lee","year":"2017","unstructured":"Lee, W. H. et al. Comparison of non-coding RNAs in exosomes and functional efficacy of human embryonic stem cell- versus induced pluripotent stem cell-derived cardiomyocytes. Stem Cells 35, 2138\u20132149 (2017).","journal-title":"Stem Cells"},{"key":"2508_CR42","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/cvr\/cvz139","volume":"116","author":"P Huang","year":"2019","unstructured":"Huang, P. et al. Atorvastatin enhances the therapeutic efficacy of mesenchymal stem cells derived exosomes in acute myocardial infarction via up-regulating long non-coding RNA H19. Cardiovasc. Res. 116, 353\u2013367 (2019).","journal-title":"Cardiovasc. Res."},{"key":"2508_CR43","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1161\/CIRCRESAHA.114.303265","volume":"114","author":"KM Michalik","year":"2014","unstructured":"Michalik, K. M. et al. Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth. Circ. Res. 114, 1389\u20131397 (2014).","journal-title":"Circ. Res."},{"key":"2508_CR44","first-page":"9739258","volume":"2019","author":"B Zhu","year":"2019","unstructured":"Zhu, B. et al. Stem cell-derived exosomes prevent aging-induced cardiac dysfunction through a novel exosome\/lncRNA MALAT1\/NF-kappaB\/TNF-alpha signaling pathway. Oxid. Med. Cell. Longev. 2019, 9739258 (2019).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"2508_CR45","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/7651_2014_119","volume":"1212","author":"N Cao","year":"2015","unstructured":"Cao, N., Liang, H. & Yang, H. T. Generation, expansion, and differentiation of cardiovascular progenitor cells from human pluripotent stem cells. Methods Mol. Biol. 1212, 113\u2013125 (2015).","journal-title":"Methods Mol. Biol."},{"key":"2508_CR46","doi-asserted-by":"crossref","unstructured":"Thery, C., Amigorena, S., Raposo, G. & Clayton, A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr. Protoc. Cell Biol. Chapter 3, Unit 3 22 (2006).","DOI":"10.1002\/0471143030.cb0322s30"},{"key":"2508_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04908-z","volume":"9","author":"S Zacchigna","year":"2018","unstructured":"Zacchigna, S. et al. Paracrine effect of regulatory T cells promotes cardiomyocyte proliferation during pregnancy and after myocardial infarction. Nat. Commun. 9, 2432 (2018).","journal-title":"Nat. Commun."},{"key":"2508_CR48","first-page":"298","volume":"113","author":"WL Tan","year":"2017","unstructured":"Tan, W. L. et al. A landscape of circular RNA expression in the human heart. Cardiovasc. Res. 113, 298\u2013309 (2017).","journal-title":"Cardiovasc. Res."},{"key":"2508_CR49","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.jacbts.2016.07.007","volume":"1","author":"MKB Jonsson","year":"2016","unstructured":"Jonsson, M. K. B. et al. A transcriptomic and epigenomic comparison of fetal and adult human cardiac fibroblasts reveals novel key transcription factors in adult cardiac fibroblasts. JACC Basic Transl. Sci. 1, 590\u2013602 (2016).","journal-title":"JACC Basic Transl. Sci."},{"key":"2508_CR50","first-page":"e52726","volume":"98","author":"AC Vandergriff","year":"2015","unstructured":"Vandergriff, A. C., Hensley, M. T. & Cheng, K. Isolation and cryopreservation of neonatal rat cardiomyocytes. J. Vis. Exp. 98, e52726 (2015).","journal-title":"J. Vis. Exp."},{"key":"2508_CR51","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/stem.1571","volume":"32","author":"Y Feng","year":"2013","unstructured":"Feng, Y. et al. Heat shock improves sca-1 stem cells survival and directs ischemic cardiomyocytes towards a prosurvival phenotype via exosomal transfer: a critical role for HSF1\/miR-34a\/HSP70 pathway. Stem Cells 32, 462\u2013472 (2013).","journal-title":"Stem Cells"},{"key":"2508_CR52","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/978-1-59745-571-8_16","volume":"139","author":"R Liao","year":"2007","unstructured":"Liao, R. & Jain, M. Isolation, culture, and functional analysis of adult mouse cardiomyocytes. Methods Mol. Med. 139, 251\u2013262 (2007).","journal-title":"Methods Mol. Med."},{"key":"2508_CR53","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1161\/CIRCRESAHA.116.309202","volume":"119","author":"M Ackers-Johnson","year":"2016","unstructured":"Ackers-Johnson, M. et al. A Simplified, Langendorff-Free Method for Concomitant Isolation of Viable Cardiac Myocytes and Nonmyocytes From the Adult Mouse Heart. Circ. Res. 119, 909\u2013920 (2016).","journal-title":"Circ. Res."},{"key":"2508_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/srep31694","volume":"6","author":"HL Glenn","year":"2016","unstructured":"Glenn, H. L., Messner, J. & Meldrum, D. R. A simple non-perturbing cell migration assay insensitive to proliferation effects. Sci. Rep. 6, 31694 (2016).","journal-title":"Sci. Rep."},{"key":"2508_CR55","doi-asserted-by":"publisher","first-page":"20130007","DOI":"10.1098\/rsif.2013.0007","volume":"10","author":"MJ Simpson","year":"2013","unstructured":"Simpson, M. J. et al. Quantifying the roles of cell motility and cell proliferation in a circular barrier assay. J. R. Soc. Interface 10, 20130007 (2013).","journal-title":"J. R. Soc. Interface"},{"key":"2508_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-017-0680-1","volume":"16","author":"H Wang","year":"2017","unstructured":"Wang, H. et al. STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4. Mol. Cancer 16, 136 (2017).","journal-title":"Mol. Cancer"},{"key":"2508_CR57","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1172\/JCI40120","volume":"120","author":"G Blin","year":"2010","unstructured":"Blin, G. et al. A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates. J. Clin. Invest. 120, 1125\u20131139 (2010).","journal-title":"J. Clin. Invest."},{"key":"2508_CR58","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/nprot.2008.116","volume":"3","author":"J Leschik","year":"2008","unstructured":"Leschik, J., Stefanovic, S., Brinon, B. & Puceat, M. Cardiac commitment of primate embryonic stem cells. Nat. Protoc. 3, 1381\u20131387 (2008).","journal-title":"Nat. Protoc."},{"key":"2508_CR59","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.0742-2822.2005.04032.x","volume":"22","author":"M Ghesani","year":"2005","unstructured":"Ghesani, M., Depuey, E. G. & Rozanski, A. Role of F-18 FDG positron emission tomography (PET) in the assessment of myocardial viability. Echocardiography 22, 165\u2013177 (2005).","journal-title":"Echocardiography"},{"key":"2508_CR60","first-page":"2346","volume":"130","author":"AJ Liu","year":"2017","unstructured":"Liu, A. J. et al. Sirtuin 1 mediates hydrogen sulfide-induced cytoprotection effects in neonatal mouse cardiomyocytes. Chin. Med. J. 130, 2346\u20132353 (2017).","journal-title":"Chin. Med. J."},{"key":"2508_CR61","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1161\/01.RES.0000134920.10128.b4","volume":"95","author":"N Takeda","year":"2004","unstructured":"Takeda, N. et al. Endothelial PAS domain protein 1 gene promotes angiogenesis through the transactivation of both vascular endothelial growth factor and its receptor, Flt-1. Circ. Res. 95, 146\u2013153 (2004).","journal-title":"Circ. Res."},{"key":"2508_CR62","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1016\/j.celrep.2015.11.005","volume":"13","author":"I Siegert","year":"2015","unstructured":"Siegert, I. et al. Ferritin-mediated iron sequestration stabilizes hypoxia-inducible factor-1alpha upon LPS activation in the presence of ample oxygen. Cell Rep. 13, 2048\u20132055 (2015).","journal-title":"Cell Rep."},{"key":"2508_CR63","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.bbrc.2017.07.108","volume":"491","author":"F Yi","year":"2017","unstructured":"Yi, F. et al. MicroRNA-193-5p modulates angiogenesis through IGF2 in type 2 diabetic cardiomyopathy. Biochem. Biophys. Res. Commun. 491, 876\u2013882 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2508_CR64","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41551-018-0239-5","volume":"2","author":"TR Heallen","year":"2018","unstructured":"Heallen, T. R. & Martin, J. F. Heart repair via cardiomyocyte-secreted vesicles. Nat. Biomed. Eng. 2, 271\u2013272 (2018).","journal-title":"Nat. Biomed. Eng."},{"key":"2508_CR65","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1161\/CIRCRESAHA.117.310803","volume":"121","author":"A Tachibana","year":"2017","unstructured":"Tachibana, A. et al. Paracrine effects of the pluripotent stem cell-derived cardiac myocytes salvage the injured myocardium. Circ. Res. 121, e22\u2013e36 (2017).","journal-title":"Circ. Res."},{"key":"2508_CR66","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1172\/jci.insight.80920","volume":"1","author":"O Bartulos","year":"2016","unstructured":"Bartulos, O. et al. ISL1 cardiovascular progenitor cells for cardiac repair after myocardial infarction. JCI Insight 1, 10 (2016).","journal-title":"JCI Insight"},{"key":"2508_CR67","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1093\/cvr\/cvu167","volume":"103","author":"L Barile","year":"2014","unstructured":"Barile, L. et al. Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction. Cardiovasc. Res. 103, 530\u2013541 (2014).","journal-title":"Cardiovasc. Res."},{"key":"2508_CR68","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41551-018-0229-7","volume":"2","author":"B Liu","year":"2018","unstructured":"Liu, B. et al. Cardiac recovery via extended cell-free delivery of extracellular vesicles secreted by cardiomyocytes derived from induced pluripotent stem cells. Nat. Biomed. Eng. 2, 293\u2013303 (2018).","journal-title":"Nat. Biomed. Eng."},{"key":"2508_CR69","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1161\/CIRCRESAHA.116.304360","volume":"116","author":"WD Gray","year":"2014","unstructured":"Gray, W. D. et al. Identification of therapeutic covariant microRNA clusters in hypoxia treated cardiac progenitor cell exosomes using systems biology. Circ. Res. 116, 255\u2013263 (2014).","journal-title":"Circ. Res."},{"key":"2508_CR70","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1161\/CIRCRESAHA.116.309307","volume":"120","author":"JH Jung","year":"2017","unstructured":"Jung, J. H., Fu, X. & Yang, P. C. Exosomes generated from iPSC-derivatives: new direction for stem cell therapy in human heart diseases. Circ. Res. 120, 407\u2013417 (2017).","journal-title":"Circ. Res."},{"key":"2508_CR71","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1161\/CIRCULATIONAHA.113.007917","volume":"130","author":"SG Ong","year":"2014","unstructured":"Ong, S. G. et al. Cross talk of combined gene and cell therapy in ischemic heart disease: role of exosomal microRNA transfer. Circulation 130, S60\u2013S69 (2014).","journal-title":"Circulation"},{"key":"2508_CR72","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1161\/CIRCRESAHA.117.311769","volume":"122","author":"M Adamiak","year":"2017","unstructured":"Adamiak, M. et al. Induced pluripotent stem cell (iPSC)-derived extracellular vesicles are safer and more effective for cardiac repair than iPSCs. Circ. Res. 122, 296\u2013309 (2017).","journal-title":"Circ. Res."},{"key":"2508_CR73","doi-asserted-by":"crossref","first-page":"18829","DOI":"10.18632\/oncotarget.4774","volume":"6","author":"X Li","year":"2015","unstructured":"Li, X. et al. Inhibition of microRNA-497 ameliorates anoxia\/reoxygenation injury in cardiomyocytes by suppressing cell apoptosis and enhancing autophagy. Oncotarget 6, 18829\u201318844 (2015).","journal-title":"Oncotarget"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2508-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2508-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2508-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T09:53:21Z","timestamp":1670234001000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2508-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,11]]},"references-count":73,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,5]]}},"alternative-id":["2508"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-2508-y","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,11]]},"assertion":[{"value":"17 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"354"}}